Extracellular matrix components and human dermal fibroblast phenotype

The term Extracellular matrix components and human dermal fibroblast phenotype refers to the complex, reciprocal relationship between the structural proteins of the dermis and the functional state of resident fibroblast cells, rather than a single molecular target. The extracellular matrix (ECM), primarily composed of Type I collagen, elastin, and glycosaminoglycans, provides the mechanical scaffold and biochemical signals necessary to maintain a stretched or active fibroblast phenotype (Fisher et al., 2008, PubMed). When the ECM is degraded—due to UV exposure or chronological aging—fibroblasts lose their mechanical attachment, leading to a collapsed phenotype characterized by reduced collagen synthesis and increased expression of matrix-degrading enzymes like MMP-1 (Varani et al., 2006, PubMed). This system is a physiological framework where specific components, such as TGF-beta receptors and integrins, are targeted by drugs like retinoids to promote ECM remodeling and skin rejuvenation (Quan et al., 2013, PubMed). Understanding this interaction is critical for developing therapies for wound healing disorders, fibrosis, and skin aging (Watt and Huck, 2013, Nature Reviews Molecular Cell Biology).

Other names

ECM-fibroblast interactionDermal matrix-cell signalingFibroblast-ECM crosstalkDermal fibroblast mechanobiology

Modulation of fibroblast gene expression and mechanical tension to stimulate extracellular matrix synthesis and inhibit degradation.